Loading…

Bacterial translocation aggravates CCl 4 -induced liver cirrhosis by regulating CD4 + T cells in rats

Bacterial translocation (BT) is thought to play an important role in the development of liver cirrhosis, but the mechanisms have not been fully explored. This study aims to investigate the distribution of Treg (CD3 CD4 CD25 Foxp3 ), Th17 (CD3 CD4 IL-17 ), and Th1 (CD3 CD4 IFN-γ ) cells in the intest...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2017-01, Vol.7, p.40516
Main Authors: Shi, Haiyan, Lv, Longxian, Cao, Hongcui, Lu, Haifeng, Zhou, Ning, Yang, Jiezuan, Jiang, Haiyin, Dong, Huihui, Hu, Xinjun, Yu, Wei, Jiang, Xiawei, Zheng, Beiwen, Li, Lanjuan
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bacterial translocation (BT) is thought to play an important role in the development of liver cirrhosis, but the mechanisms have not been fully explored. This study aims to investigate the distribution of Treg (CD3 CD4 CD25 Foxp3 ), Th17 (CD3 CD4 IL-17 ), and Th1 (CD3 CD4 IFN-γ ) cells in the intestinal lamina propria, liver and blood and to explore their relationships with BT. Cirrhotic rats with ascites were induced by CCl . We found that there were lower levels of total protein and albumin, lower albumin/globulin ratio, lower body weight and higher spleen weight and ascites volume in cirrhotic rats with than without BT. We found that BT may cause increase of Treg cells in the proximal small intestine and decrease of Th17 cells in the whole intestine and blood in cirrhotic rats. It may also aggravate the CCl -induced decrease in Th1 cells in the whole intestine, liver, caecum, and blood and the CCl -induced increase in Th17 cells in the liver and Tregs in the distal small intestine, colon, and liver. Our data suggest that BT may aggravate liver injury and decrease liver function via an interaction with CD4 T Cells. The results of this study may be helpful for the development of new treatments for liver cirrhosis.
ISSN:2045-2322
DOI:10.1038/srep40516